AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

GlycoMimetics to Present at the Piper Jaffrey 31st Annual Healthcare Conference 2019

November 29, 2019

ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 29, 2019--

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Chief Executive Officer Rachel King will provide a company overview at the Piper Jaffrey 31 st Annual Healthcare Conference in New York, New York, which takes place on December 3, 2019. Ms. King’s presentation is scheduled for 1:30 p.m. ET.

To access the live webcast and subsequent archived recordings for this presentation, please visit the GlycoMimetics website at www.glycomimetics.com.

About GlycoMimetics, Inc.

GlycoMimetics is a clinical-stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. GlycoMimetics’ wholly-owned drug candidate, uproleselan, an E-selectin antagonist, was evaluated in a Phase 1/2 clinical trial as a potential treatment for AML and is being evaluated across a range of patient populations including a Company-sponsored Phase 3 trial in relapsed/refractory AML. GlycoMimetics has also completed a Phase 1 clinical trial with another wholly-owned drug candidate, GMI-1359, a combined CXCR4 and E-selectin antagonist. GlycoMimetics is located in Rockville, MD in the BioHealth Capital Region. Learn more at www.glycomimetics.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191129005249/en/

CONTACT: Investor Contact:

Shari Annes

Phone: 650-888-0902

Email:sannes@annesassociates.comMedia Contact:

Jamie Lacey-Moreira

Phone: 410-299-3310

Email:jamielacey@presscommpr.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK MARYLAND

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH SCIENCE PHARMACEUTICAL RESEARCH

SOURCE: GlycoMimetics

Copyright Business Wire 2019.

PUB: 11/29/2019 09:41 AM/DISC: 11/29/2019 09:40 AM

http://www.businesswire.com/news/home/20191129005249/en